Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-SARS-CoV-2 Antibody Testing: Role and Indications. | J Clin Med | 2023 | 38137643 | PubTator, text mining | PubMed |
| Deep-Sea Sponges and Corals off the Western Coast of Florida-Intracellular Mechanisms of Action of Bioactive Compounds and Technological Advances Supporting the Drug Discovery Pipeline. | Mar Drugs | 2023 | 38132936 | PubTator, text mining | PubMed |
| Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period. | Signal Transduct Target Ther | 2023 | 38129394 | PubTator, text mining | PubMed |
| Newer emerging SARS-COV2 variant: Omicron EG.5. | Ann Med Surg (Lond) | 2023 | 38098560 | PubTator, text mining | PubMed |
| Carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells. | Cell Death Discov | 2023 | 38086808 | PubTator, text mining | PubMed |
| The Many Mutations of the COVID-19 Variant: Current Perspectives on EG.5/Eris. | Environ Health Insights | 2023 | 38084254 | PubTator, text mining | PubMed |
| Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study. | Int J Reprod Biomed | 2023 | 38077941 | PubTator, text mining | PubMed |
| Ceramides in peripheral arterial plaque lead to endothelial cell dysfunction. | JVS Vasc Sci | 2023 | 38077163 | PubTator, text mining | PubMed |
| Analysis of gene expression profile for identification of novel gene signatures during dengue infection. | Infect Med (Beijing) | 2023 | 38076406 | PubTator, text mining | PubMed |
| A Sanger approach based on overlapping fragments to screen SARS-CoV-2 variants. | Heliyon | 2023 | 38076162 | PubTator, text mining | PubMed |
| Integrated analysis of the potential roles of microRNA-messenger RNA networks in prostate adenocarcinoma. | Heliyon | 2023 | 38076048 | PubTator, text mining | PubMed |
| Analysis of a Four-Component Competing Endogenous RNA Network Reveals Potential Biomarkers in Gastric Cancer: An Integrated Systems Biology and Experimental Investigation. | Adv Biomed Res | 2023 | 38073751 | PubTator, text mining | PubMed |
| Molecular Profiling of Lymphatic Endothelial Cell Activation In Vitro. | Int J Mol Sci | 2023 | 38068914 | PubTator, text mining | PubMed |
| Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers. | Biomed Res Int | 2023 | 38046902 | PubTator, text mining | PubMed |
| Designer Adaptor Proteins for Functional Conversion of Peptides to Small-Molecule Ligands toward In-Cell Catalytic Protein Modification. | ACS Cent Sci | 2023 | 38033808 | PubTator, text mining | PubMed |
| Genetic detection of two novel LRP5 pathogenic variants in patients with familial exudative vitreoretinopathy. | BMC Ophthalmol | 2023 | 38030997 | PubTator, text mining | PubMed |
| Safeguarding India Amidst the EG.5 Variant: A Pragmatic Outlook. | Microbiol Insights | 2023 | 38025897 | PubTator, text mining | PubMed |
| Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach. | RSC Adv | 2023 | 38019988 | PubTator, text mining | PubMed |
| Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. | Cell Death Dis | 2023 | 38012214 | PubTator, text mining | PubMed |
| Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer. | Pharmaceutics | 2023 | 38004560 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=16